Cambridge Healthtech Institute, Lake Buena Vista, Florida
February 9-11, 2005
Join R&D leaders at the most prominent executive meeting of the year. Hundreds of past Pharmaceutical Strategy Series senior-level participants will convene in Walt Disney World for the Annual Leaders' Summit to discuss the most pressing issues facing the industry. This multi-track event will feature sessions on:- Evaluating the Portfolio Decision Making Process and the Stagegate Criteria Used in Making Go/No-Go Decisions - Developing a Portfolio with Limited Attrition - How to Grow Profits via Larger Portfolios that Feature Less Blockbusters - Evaluating R&D Business Models of the Top Companies in the World - What Works Best and Why? - How Can Pre-Clinical Discovery and Phase I Development Better Integrate Knowledge, Data and an Overall Strategic Approach to Addressing a Candidate? - Pinpointing the Key Areas in which to Make Improvements When Moving a Drug from Phase IIa to IIb to III - Why Lead Optimization Has Failed and What the Industry Can Do to Improve the Quality of Leads - Which Predictive Technologies Will Be Most Useful Over the Next Five Years? - What Can Pharmaceutical Companies Do to Benefit More from Collaborations? - Strategies to Best Integrate Smaller, Innovative Companies into a Big Pharma - How Can the Industry Best Leverage Biomarkers to Improve Overall Productivity? - What Are the Best Process to Continuously Measure ROI of Novel Technologies? - What are the Most Important Indicators of R&D Productivity? - Reducing Clinical Timelines and Attrition Rates through Effective Partnering with the FDA - Creating Lower Cost, Lower Risk Opportunities by a Strategic Informatics Approach Linking Mechanisms, Indications and Molecules
|
|